Corise Zeronac-ET Tablets

Corise Zeronac-ET Tablets | Etamsylate & Tranexamic Acid for Dogs and Cats

Zeronac-ET Tablets by Corise Healthcare combine the powerful effects of Etamsylate (250 mg) and Tranexamic Acid (500 mg) to effectively control and prevent bleeding in pets. Specially formulated for veterinary use, these tablets are widely recommended to manage hemorrhage, trauma-related bleeding, post-surgical blood loss, and other clotting disorders in dogs and cats.

Key Features

• Controls Bleeding: Helps reduce or stop excessive bleeding caused by surgery, injury, or medical conditions.

• Dual-Action Formula: Combines Etamsylate (enhances platelet function) and Tranexamic Acid (reduces fibrinolysis).

• Supports Recovery: Aids in post-operative healing and strengthens capillary walls to prevent re-bleeding.

• Veterinarian Recommended: Safe, effective, and trusted for clinical use in dogs and cats.

• Easy to Administer: Film-coated tablets for easy oral use.

Composition (per tablet)

• Etamsylate IP: 250 mg

• Tranexamic Acid IP: 500 mg

• Excipients: q.s.

• Colour: Erythrosine & Titanium Dioxide

Dosage & Administration

To be given as directed by the veterinarian based on pet’s condition, age, and weight.

Product Details

• Brand: Corise Healthcare

• Product Name: Zeronac-ET Tablets

• Active Ingredients: Etamsylate + Tranexamic Acid

• Type: Hemostatic & Antihemorrhagic Veterinary Tablets

• For Use In: Dogs & Cats

• Pack Size: 10 Tablets per strip

• Storage: Store in a cool, dry place away from sunlight and moisture.

• Manufacturer: Devbhoomi Pharmaceuticals, Uttarakhand, India

• Marketed by: Corise Healthcare Pvt. Ltd., Thane, Maharashtra, India

Precautions

• For veterinary use only.

• Keep out of reach of children.

• Use only under the guidance of a licensed veterinarian.